Abstract

Background: Cryptosporidiumspp. are protozoan parasites that cause diarrhea in humans and animals. Subtyping data about Cryptosporidiumspp. in Isfahan, Iran is limited; therefore, we aimed to study the prevalence rate of Cryptosporidiumspp. in cancer patients, associated risk factors, and subtypes of Cryptosporidiumspp.

Methods: Fecal samples were collected from 187 cancer patients from the Oncology Department of Seyed-al-Shohada Hospital, Isfahan University of Medical Sciences during 2014–2020 and screened for Cryptosporidiumspp. using microscopical techniques. Nested PCR amplifying 18S rRNA gene was used to detect Cryptosporidiumspp. in samples, followed by subtyping using nested PCR amplifying gp60 sequences.

Results: Overall, the rate of infection with Cryptosporidiumspp. was 4.3% (n=8). Five samples out of eight samples were identified as Cryptosporidiumspp. using a nested PCR for the 18S rRNA gene, two subtypes of C. parvum named IIaA18G3R1 (n = 2) and IIaA17G2R1 (n = 2), and one subtype of C. hominis named IbA6G3 were identified by sequencing of the gp60. The IbA6G3 subtype has rarely been detected in other investigations.

Conclusion: This is the first survey on the subtyping of Cryptosporidiumspp. in this region. The results of the present survey show both zoonotic and anthroponotic transmission routes in the region.

Details

Title
Identification and Subtyping of Cryptosporidium parvum and Cryptosporidium hominis in Cancer Patients, Isfahan Province, Central Iran
Author
Pestechian, Nader  VIAFID ORCID Logo  ; Reza Mohammadi Manesh; Tavakoli, Sanaz; Mokarian, Fariborz; Rahmani, Maryam  VIAFID ORCID Logo 
Pages
497-505
Section
Original Article(s)
Publication year
2022
Publication date
2022
Publisher
Tehran University of Medical Sciences
ISSN
17357020
e-ISSN
2008238X
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2756685508
Copyright
© 2022. This work is published under https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.